BMC Biochemistry                                                                                                                         BioMed Central



Research article                                                                                                                       Open Access FF domains yeast U1 snRNP protein Prp40 mediate
interactions Luc7 Snu71
Claudia Ester1 Peter Uetz*1,2

Address: 1Forschungszentrum Karlsruhe, Institute Toxicology Genetics, P. O. Box 3640, D-76021 Karlsruhe, Germany 2J Craig Venter
Institute (JCVI), 9704 Medical Center Drive, Rockville, MD 20850, USA
Email: Claudia Ester - claudia.ester@itg.fzk  Peter Uetz* - uetz@jcvi.org
* Corresponding author




Published: 11 November 2008                                                   Received: 4 June 2008
                                                                              Accepted: 11 November 2008
BMC Biochemistry 2008, 9:29   doi:10.1186/1471-2091-9-29 article available  http://www.biomedcentral.com/1471-2091/9/29
© 2008 Ester Uetz; licensee BioMed Central  Open Access article distributed terms Creative Commons Attribution License (http://creativecommons.org/licenses 2.0), permits unrestricted use, distribution, reproduction medium, provided original work properly cited.




                 Abstract
                 Background: FF domain conserved eukaryotes usually acts adaptor
                 module RNA metabolism transcription. Saccharomyces cerevisiae encodes FF domain
                 proteins, Prp40, component U1 snRNP, Ypr152c, protein unknown function.                  structure Prp40, relationship proteins U1 snRNP, precise function
                 remain little understood.
                 Results: investigated essentiality interaction properties FF domains
                 yeast Prp40. C-terminal FF domains Prp40 dispensable. Deletion
                 additional FF domains lethal. FF domain Prp40 binds U1 protein Luc7 yeast
                 hybrid GST pulldown experiments. FF domains 2 3 bind Snu71, known U1
                 protein. Peptide array screens identified binding sites FF1-2 Snu71 (NDVHY) FF1
                 Luc7 (ϕ[FHL] × [KR] × [GHL] ϕ hydrophobic amino acid).
                 Conclusion: Prp40, Luc7, Snu71 appear form subcomplex yeast U1snRNP.
                 data suggests N-terminal FF domains critical interactions. Crystallization
                 Prp40, Luc7, Snu71 failed far crystallization pairs tri-complex
                 facilitate crystallographic functional analysis.




Background                                                                     yeast essential U1snRNP component Prp40 plays
Spliceosome assembly yeast occurs stepwise man-                        important role bringing 5' 3' splice sites ner U1, U2, U4/U6 U5 snRNPs binding sequen-                           spatial proximity intron spliced tially pre-mRNA  defined                       pre-mRNA [1]. Ito et al[11] Prp40 interact
step building commitment complex yeast                        Snu71 "core" yeast hybrid (Y2H) E complex metazoans U1snRNP binds                          data. knowledge, direct interaction initially 5' splice site. metazoan U1snRNP                      Prp40 Luc7 reported proteins
tains proteins U1  U1-70K U1-C. yeast                            complex multiple times (e.g.
U1snRNP contains homologs proteins,                               [12,13]).
Mud1, Snp1 Yhc1, seven additional pro-
teins [1-10].                                                                  Prp40 modular protein consisting pair WW
                                                                               domains followed series FF domains (Fig. 1).


                                                                                                                                       Page 1 11
                                                                                                                 (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                         http://www.biomedcentral.com/1471-2091/9/29




                                           Preys:        Snu71                   Luc7

                                                      wt           II       wt             II

                                             FF1

                                             FF2

                                             FF3
                        Prp40 domain baits




                                             FF4

                                             FF1-2

                                             FF2-3

                                             FF3-4

                                             FF1-3



             B                                              Yeast U1snRNP proteins
                                                                                                                           II

                                                             Snu71                                                        PWI
                                                             Mud1                                             x
                                                                                                                                                                               Prp39                       FF1-3
                                                             Prp42
                                                             Prp40        W    W   F1    F2         F3        F4
                                                             Snp1                  FF1
                                                             Snu56
                                                             Nam8
                                                             Yhc1                         II
                                                                                               x
                                                             Luc7
                                                                               

FigureFF1 domains 1–3 bind Snu71 FF domain 1 binds Luc7 II
Prp40
Prp40 FF domains 1–3 bind Snu71 FF domain 1 binds Luc7 II. Binding sites FF domains Luc7 Snu71 roughly mapped Yeast-2-hybrid assays.  hybrid assay testing binding Prp40 FF domain constructs
(FF1, FF2, FF3; FF4, FF1-2, FF2-3, FF3-4, FF1-3) length clones fragments Snu71 Luc7  domains frag-
ments panel B). encircled colony indicates hybrid interaction (weak interactions hatched circles). B, Sche-
matic overview Prp40 FF domain interactions (arrows) U1snRNP proteins Snu71 Luc7 context U1snRNP illustrated human U1snRNP (modified [9]). Note structural model human U1snRNP
does include proteins studied  dashed line extending FF1 domain indicates length
Snu71 interacts FF2-3 Snu71 interacts domains FF1-3.




                                                                                                                                Page 2 11
                                                                                                         (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                http://www.biomedcentral.com/1471-2091/9/29



FF domains described 1999 Bedford &          Saccharomyces cerevisiae Gal4-activation domain
Leder domains 60 amino acids including        fusions (preys [25]). screens resulted conserved Phenylalanines (F) domain       interaction partners, Snu71 Luc7, known
named [14]. Typically FF domains occur tandem arrays.      components U1 snRNP [12,13,26]. interaction example, 78 metazoan FF domain proteins         partners identified length Ypr152c
listed SMART database [15], 13 2 3 FF          protein, FF domain bait.
domains, 4 6. structure FF domains solved recently: FF1            Prp40 identified interacting bait, cloned
domain human protein HYPA/FBP11, FF1               FF domains combinations thereof tested domain yeast protein Prp40, single FF          baits fragments Snu71 Luc7 preys  domain Urn1/Ypr152c [16-18]. FF domain proteins            methods domain definitions). experiments classified families: p190 Rho GTPase-       showed FF1 domain Prp40 binds C-termi-
related proteins [19] WW/FF family mem-         nal fragment Luc7 (Luc7 II, Fig. 1). Similarly, C-termi-
bers contain WW domains followed           nal fragment Snu71 (Snu71  binds Prp40 FF
eral FF domains. proteins family      domains 1–3. Interestingly, length Snu71 known recognize phosphorylated C-terminal              Snu71 interacts FF2-3 domain fragment (Fig.
domain (CTD) RNA polymerase II FF            1).
domains, human transcription elongation fac-
tor CA150, human splicing factor FBP11 yeast      screened isolated domains combinations
splicing factor Prp40 [16,20-22]. Furthermore, FF             thereof baits genome-wide prey array. 
domains CA150 use multiple independent              new proteins way: FF1-4 inter-
binding sites bind cooperatively proteins   acted Snu71 Luc7, FF1-3 FF2-3 transcription splicing associated factor      interacted Snu71 Luc7 screens
Tat-SF1 [23]. FF1 domain Prp40 known inter-      (data shown).
act Clf1 (Crooked neck-like factor), essential conserved multifunctional protein [24]. role      results encouraged revisit protein topology second yeast FF protein, Urn1/Ypr152c,          U1 snRNP. tested U1snRNP associated pro-
tains WW domain FF domain, splic-        teins systematic pairwise yeast hybrid tests using
ing factor [18].                                          length bait prey constructs                                                               previously detected interactions Prp40-Snu71 Prp40- investigated role FF domains     Luc7.
binding specificity. specifically, study aims complement data order define consensus          verify yeast hybrid experiments inde-
binding site FF domains, sites known    pendent method performed GST pulldowns. Different domains SH3 domain  consensus         FF domains expressed GST fusion proteins E.
binding site "proline-rich"). addressed problem    coli purified glutathione sepharose beads. Surpris- combination genome-wide yeast hybrid              ingly, protein constructs containing FF3 domain 
screens, vitro binding assays, peptide arrays,         sistently failed expressed significant amounts. genetic experiments.                                          conclude FF3 domain renders FF3, FF2-3, FF1-
                                                              3 FF1-4 constructs insoluble unstable. FF domains Prp40          Snu71 Luc7 translated 35S- essential explain behaviour interac-    labeled vitro incubated remaining GST-FF
tions components yeast U1 snRNP.        fusion proteins. experiments clearly showed binding site significantly differs previ-   Luc7 binds specifically FF1 possibly FF2
ously published binding sites FF domains          domains Prp40 binding FF2 signfi-
implicates FF domains interaction modules       cantly weaker FF1 (Fig. 2). Unfortunately, wide range specificities, stark contrast     interaction Prp40-FF1-3 Snu71 domains SH3 PDZ domains.                           confirmed way involved inaccessible FF3
                                                              domain.
Results
Prp40 interacts Luc7 Snu71 FF domains        FF domains bind specific peptides Luc7 Snu71 investigate interaction properties yeast FF         hybrid mapping experiments did provide domains, screened Prp40 Urn1/Ypr152c          information precise binding sites Prp40 isolated FF domain baits genome       FF domains Luc7 Snu71. order map wide yeast hybrid arrays containing ORFs       binding sites Prp40 FF domains synthesized


                                                                                                                  Page 3 11
                                                                                            (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                 http://www.biomedcentral.com/1471-2091/9/29




                                                                 GST-Prp40-                                        GST

                       L      Luc7               FF1 FF2 FF4 FF1-2 FF3-4

  66 kDa
  45 kDa

  31 kDa




   Luc7


Figure FF12domain Prp40 binds Luc7 vitro FF1 domain Prp40 binds Luc7 vitro. Various GST-Prp40FF domain fusion proteins (FF1, FF2; FF4, FF1-2,
FF3-4) tested Luc7 binding vitro. panel shows Coomassie blue-stained GST fusion proteins, row
shows autoradiography bound Luc7 protein. Luc7 bound construct containing FF1-2 domains FF1
domain  barely FF2   input; L, ladder (molecular mass marker).


overlapping 15-mer peptides Luc7 Snu71 nitro-        ing motif generalized ϕ[FHL] × [KR] × [GHL]
cellulose membranes probed GST-FF                ϕ hydophobic amino acid (Fig. 3E).
domain fusions (Fig. 3). peptides used covered         Interestingly, Luc7 binding site showed similarity
regions Luc7 (amino acids 93–261) Snu71 (amino                   interaction   region     (peptide    B1:
acids 329–536) shown interact Y2H assays       H418LANDVHYDHHRSFK432) Snu71 (Fig. 1). screens identified peptide C-termi-   obtained approach (Fig. 3A). consistent
nal half Luc7, D214RRLADHFLGKIHLG228 (A24),            interaction region (N421DVHY) narrowed appeared primary interactor FF1 domain        overlapping peptides detected Snu71 II (Figs. 3B–D). results shown Figures 3A–B       synthesised CAPE-membrane 20-mer overlapping
used fusion FF1-2 explicit goal project    peptides 3 amino acid shifts probed GST- identify targets single FF domains. follow-    FF1-2.
ing experiments (Figs. 3C–D) carried FF1 domain appeared contribute binding (Fig.       FF1 FF2 domains essential yeast Prp40
2). A24 peptide characterized systematic            hybrid mapping experiments indicated
alanine scans (Fig. 3C) substitution analysis (Fig. 3D)    FF domains Prp40 impor- define critical amino acids interaction    tant ones, physiological role remained unclear. FF1 domain Prp40. analysis clearly showed          determine physiological role FF domains importance FLGKIH motif binding – Gly-         Prp40 deleted FF domains starting cine-223 Histidine-226 important           C-terminus vivo (Fig. 4). mutant strain binding. Based substitution analysis interact-     deleted FF domain replaced proteinA/kanMX6


                                                                                                                  Page 4 11
                                                                                            (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                                                 http://www.biomedcentral.com/1471-2091/9/29




                                        Snu71 peptides probed GST-FF1-2
                                                                       1   2   3   4   5   6   7   8   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

                                                                      B
                                   C                                                                               controls




                               B        Luc7-II peptides probed GST-FF1-2
                                        1   2   3   4   5   6   7   8   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

                                                                      B



                               C        Luc7 peptides, probed GST-FF1
                                                                                            E                   Luc7-peptide sequence
                               wt D R R L D H F L G K H L G                                                 F L G K H L G
                                                                                                            Y     Y     Y           Y
                                                                                                            W   W W W W W W         W   W
                                                                                                            V           V           V
                               D       Luc7 peptide sequence (           = wildtype)                        T     T T   T T         T T
                                   D R R L D H F L G K H L G                                            S     S S   S S         S S
                               Y                                                                            R     R R R R R         R R
                               W                                                                            Q     Q Q   Q           Q Q
                               V                                                                            P     P P   P P           P
                               T
                                                                                              amino acids


                                                                                                            N     N N   N N         N N
                               S
                                                                                                            M     M M   M M         M M
                               R
                                                                                                            L   L L       L         L L
                               Q
                               P                                                                            K         K
                               N                                                                                                               amino acids




                               M                                                                            H     H H     H         H H
                               L                                                                            G     G G G G G         G G
                               K                                                                            F   F F                 F F
                                                                                                          E
                               H                                                                            D                           D
                               G                                                                            C
                               F
                                                                                                                                                     E
                               D                                                                                  F             G
                               C                                                                                1 H x K x H x x
                                                                                                                _
                                                                                                                L     R       L

Figure
FF  domains
         3 Prp40 bind specific peptides Snu71 Luc7
FF domains Prp40 bind specific peptides Snu71 Luc7.  Peptides Snu71 (aa 329–536) Luc7-
II (aa 93–261) synthesised 15 mers 3 aa shifts β-alanine membrane. control peptide (QRALAKDLIVPRRP,
position C17) binds α-GST antibody. Incubation GST-FF1-2 showed strong signal peptide B1 A24 (panel
B). B, Peptide scan Luc7 peptides probed GST-FF1-2. Control membranes probed GST negative (data shown). C, Alanine-scan peptide B (position A24, wildtype sequence: DRRLADHFLG-
KIHLG). Letters mark amino acids replaced alanine. GST-FF1 served probe. important amino
acid interaction shown bold. D, Substitution analysis Luc7 peptide sequence C, probed GST-FF1. residue sequence substituted 20 naturally occurring L-amino acids. spots circles represent wild-type amino acids. spots single substitution analogs, rows defining sequence position substi-
tuted columns defining amino acid replaces wild-type residue. E, Luc7 motif bound FF1 domain Prp40 D. ϕ stands hydrophobic amino acids, green indicates hydrophobic, yellow indicates polar, blue indicates
basic orange indicates acidic amino acids. White letters black background represent wildtype amino acids sequence.



                                                                                                                                                     Page 5 11
                                                                                                                               (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                   http://www.biomedcentral.com/1471-2091/9/29



cassette selection deletion mutants easy protein     showed FF1 domain Prp40 responsible
detection (Fig. 4A). unable isolate deletion       binding Luc7 region FF1-3 binds FF domain 4 assumed essential.         length Snu71 C-terminal fragment  deletion FF domains 3–4 (FFΔ3-4ProA)           Snu71  fragment containing FF2-3 binds 
viable albeit showed clear growth defect com-         length Snu71 Snu71  suggests bind-
pared control constructs (FF1-4ProA, e. wildtype       ing cooperative regions outside Snu71 Prp40 Protein fused C-terminus            present additional binding sites.  single
wildtype control strain PJ69-4α) (Fig. 4B). Deletions FF     binding site indicates strong site
domains 2–4 1–4 appear lethal         N421DVHY motif. case, results  isolate mutants. results confirmed ini-      firm different FF domains clearly different bind-
tial hybrid findings indicated FF1 FF2       ing specificities FF1-2 region business critical Prp40 FF3 FF4             end Prp40 [17].
increase activity stability.
                                                                ability FF domains bind non-phosphorylated
FFΔ3–4 deletions inhibit splicing DBP2            peptides refutes suggestion FF domain ECM33                                                           exclusively phospho-peptide binding domain. Prp40 established component U1
snRNP, reasoned phenotype probably        FF domain binding sites identified study defect splicing. investigate question, tested   Luc 7 Snu71 share obvious similarity
splicing efficiency selected Saccharomyces cerevisiae    previously identified binding motifs (Table 1). 
intron-containing genes, DBP2 ECM33,              eral studies showed FF domains bind phospho-
commonly used splicing reporters.  RT-PCR            peptides, usually phospho-CTD RNA polymerase II
assays RNAs genes revealed splicing      (Table 1). Similarly, FF domains CA150 defect FFΔ3–4 mutant (data shown).                   shown bind acidic peptides.                                                                  true Prp40 FF domains 2–3 FF1 domain Discussion                                                      protein appears prefer basic residues. finding composition yeast U1 snRNP          agreement acidic nature Prp40-FF1 (bind- known decade [12,13] precise interactions        ing basic peptides) basic FF2 FF3 domains components atomic structure remain          bind acidic Snu71 peptide. Unfortu-
elusive. Equally puzzling fact human U1         nately little information derive reliable
snRNP commonly assumed consist 10 proteins             consensus binding sites. Similarly, available 3D structures
(U1  U1-70K U1-C plus seven Lsm proteins               FF domains bound cognant ligands addition snRNAs) [9,27] yeast counterpart      sufficient derive rules allow predict binding
contains 18 proteins [12,13]. species U1        sites generally. Clearly, structural work U1-70K U1-C (Mud1, Snp1, Yhc1 yeast) form              required understand binding mode FF domains.
complex associated heptameric Sm protein
ring complex [9]. Mud1-Snp1-Yhc1 core            Murphy et al. [31] investigated functional role complex Lsm ring little information available        motifs Prp40, including putative RNA-binding structure yeast U1 snRNP. complex         domains "region 1" "region 2" purification studies large complexes 10 51 pro-      overlap FF domains (Figure 4C). teins individual U1 components used baits           deletion region 1 lethal, deletion region 2 resulted
[10,28]. suggest Prp40, Luc7, Snu71            slow growth phenotype.  Murphy et al. form subcomplex U1 snRNP. Surprisingly,            able RNA-binding "domains" did interaction U1snRNP        likely similarity RNA-binding systematically tested pairwise interactions         domains spurious. fact overlap signifi- known 10 subunits, suggesting limitations        cantly FF domains supports notion.  yeast hybrid requirement           theless, deletion region 2 partially deletes FF2
RNA prevented detection interactions.          domain. possible truncated FF2 domains U1snRNP associated proteins contain RNA binding             residual binding activity shows domains known bind RNA directly [29,30].             "slow growth" defect. tested Interestingly, did known Prp40 inter-       partial deletion FF2 binds Snu71 given actor, Clf1 [24], initial genome-wide yeast          non-essential role Snu71, binding abso-
hybrid screen.  subsequent verification          lutely required U1 function.
pertinent array position revealed Clf1 ORF missing prey array.


                                                                                                                     Page 6 11
                                                                                               (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                         http://www.biomedcentral.com/1471-2091/9/29




                          construct                    Prp40FF deletion                            phenotype


                            FF1-4 ProA    WW       WW    FF1   FF2          FF3         FF4   ProA         vital


                            1 FF4 ProA    WW       WW    FF1   FF2          FF3   ProA                    lethal ?



                        1 FF3-4 ProA
                                          WW       WW    FF1   FF2   ProA                            Slow growth


                                           WW      WW    FF1   ProA                                       lethal ?
                        1 FF2-4 ProA




               B                                   growth defect
                                                                                              wt control PJ69-42
                                                                                              FF1-4ProA



                                                                                              1 FF3-4 ProA
                   OD 600




                                                    time (min)

               C
                                                132-188 201-257 ~280 ~345 348-359 355-413            493-552


                               W W                 F1     F2                       F3                 F4
                                                                 NES1 NES2 ARM
                                                    Region 1 Region 2
                                                    175-218 235-281
                               Mutant phenotype:    1:lethal 1:slow growth 36°ts   wt     33° ts


Figure  Prp40
        4 FF domains 1–2 essential vivo Prp40 FF domains 1–2 essential vivo.  strain Protein fused length Prp40 (FF1-4ProA)
shows signficant difference growth wild-type. FF domain deletions C-terminus insertion Protein respective FF domain locus resulted viable mutant lacks FF domains 3–4.  replacements FF
domains 4 3–4 lethal. B, mutant lacking FF domains 3–4 viable shows growth defect compared wild-type controls. C, Summary domains functional motifs Prp40. Numbers amino acid sequence positions. Regions 1 2 similar RNA-binding domains. motifs, NES 1 2 (nuclear export signals) arginine-rich motif (ARM) deleted [Δ] mutated Murphy et al. [31]. phe-
notypes mutations shown (ts = temperature-sensitive). Note predicted coiled-coil region indicated bar FF2 FF3 shown known function.




                                                                                                                            Page 7 11
                                                                                                      (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                                http://www.biomedcentral.com/1471-2091/9/29


Table 1: Binding sites FF domains

 FF protein        FF domain          Target protein           Binding site                                                        Ref.

 Prp40             FF1                Clf1                     GSTNIDILDLEELREYQRRKRTEYEGYLKRNRLD                                  [17]
 Prp40             WW+FF1-2           RNAPII-CTD               YpSPTpSPS                                                           [22]***
 Prp40             FF1                Luc7                     φ[FHL] × [KR] × [GHL] = FLGKIHLG                                    study
 Prp40             FF2-3              Snu71                    NDVHY                                                               study
 CA150             FF1,2,3**          Tat-SF1                  (D/E)2/5-F/W/Y-(D/E)2/5 *                                           [23,21]
 CA150             FF5                RNAP-CTD                 YpSPTpSPS                                                           [20]
 FBP11             FF1                RNAP-CTD                 YpSPTpSPS                                                           [16]
 Rho-GAP           FF1-4              TFII                   (N-terminal 90 amino acids)                                         [15]

 * e., residues preceding following aromatic residue negatively charged glutamic acid asparagine.
 ** FF1, FF2, FF3 bound similar affinity.
 *** interaction required WW FF domains. able bind CTD itself (pS indicates phospho-Serine).
 role Snu71 remains elusive  Newo et al. [32]                   dispensable, convey considerable growth disadvan- analyzed U1 snRNP Schizosaccharomyces pombe                   tage absent. conclude assist homolog Snu71 homologs                        spliceosome assembly activity. reflected Prp40 Luc7 clearly present.  spec-                  evolutionary conservation 4  5, FF
ulate Usp107p functional homolog                         domains homologous proteins. suggest Snu71, given similar size presence PWI                   observations help characterize U1 snRNP
domain Usp107p.                                                        structurally suggest previous crystallization
                                                                          efforts failed Luc7 Snu71 expressed Prp40 does bind conserved sequence                      individually crystallization attempts included Snu71, binding site Luc7 highly conserved.                 individual proteins. speculate Luc7 rigorous confirmation specificity Prp40                crystallized Prp40 fragments thereof. Fur- FF domains, interesting compare                  ther studies required derive general rules physi- peptide-binding specificities available domains                ological FF domain functions activities. cognate peptides comparable conditions.
Similarly, vivo relevance interactions                      Methods
described elucidated detailed struc-                2.1. Plasmids Strains
tural analysis mutation interaction epitopes                pOBD2 pOAD [36] low-copy plasmids used vivo.                                                                     express fusions Gal4-Gal4 activation domain (AD)
                                                                          (preys) Gal4 DNA binding domain (DBD) (baits). detailed understanding U1 protein function, crys-
tal structures individual proteins  preferably,             Construction Gal4DBD-ORF fusions performed complex, required. structure                 means PCR recombination [37] described tell FF domains Prp40 bind 3-dimen-                  [25]. Transformation performed using lithium
sional epitopes linear motifs. membrane-                     acetate procedure [38]. Bait constructs transformed
bound peptides used study folded                 yeast strain PJ69-4α [36] prey constructs native protein, produce artifactual results.              PJ69-4a [39].
 study provide new insight                       Y2H mapping experiments FF domain constructs important role Prp40 mediator transcrip-                  Prp40 baits Snu71 prey produced
tion splicing. Prp40 consistently                      using following primers (forward primers shown shown component U1 snRNP, precise                      codons): ForwardFF1: TTC CAG CTG ACC ACC ATG
role splicing remains unclear. Similarly, mechanis-                AGA AGG ACT AAA GAA GAA, ReverseFF1: GA TCC CCG
tic details involvement transcription require addi-             GGA ATT GCC ATG TGT TTC ATT GTG TTC CT,
tional data. publications indicate direct                       ForwardFF2: TTC CAG CTG ACC ACC ATG AAG GAA
connection specific steps transcription                    CAC AAT GAA ACA, ReverseFF2: GAT CCC CGG GAA TTG
mRNA-processing eukaryotes,  e. transcriptional                   CCA TGG ATT CTT TCT GAG TGT CG, ForwardFF3: TTC
mRNA-processing [33-35].                                                  CAG CTG ACC ACC ATG AAT TAT ACC AGA GAC CGT,
                                                                          ReverseFF3: ATC CCC GGG AAT TGC CAT GAC GTC TGT
Conclusion                                                                TGG GCT ATT G, ForwardFF4: TTC CAG CTG ACC ACC results FF domains 1 2 critical                 ATG CAA AAT GAG CGT AGG ATA, ReverseFF4: GAT CCC
Prp40 function.  FF domains 3 4                     CGG GAA TTG CCA TGC GCT TTC GGC AGT CGG,


                                                                                                                                   Page 8 11
                                                                                                             (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                  http://www.biomedcentral.com/1471-2091/9/29



ForwardSnu71II: AA TTC CAG CTG ACC ACC ATG TCC                  pled reticulocyte presence [35S] methio-
GAG AGA AGC GCG GCA GAG, ReverseSnu71II: GAT                    (Promega, Madison, WI). PCR primers CCC CGG GAA TTG CCA TGC TCT GCC GCG CTT CTC                     follows: Luc7p Forward: GGATCCTAATACGACTCAC-
TCG GA, ForwardSnu71I: AA TTC CAG CTG ACC ACC                   TATAG GGAAACAGCCACCATGTCAACTATGTCAACGC
ATG GCC AAA GGG AGC GCC AAT ACA, ReverseSnu71I:                 CT, Luc7p Reverse: CTA CAC AAA GCG TCT TCC GGG;
GAT CCC CGG GAA TTG CCA TGT GTA TTG GCG CTC                     Snu71p Forward: ATCCTAATACGACTCACTATAG GGAA
CCT TTG GC. PCR reactions using primers resulted          ACAGCCACCATGAGGGAT ATTGTATTTGTA, Snu71p following Gal4-DBD GST fusion constructs          Reverse: TCA GGT CCC CAA GCG AAA TTC.
 based wildtype sequences http://www.yeast
genome.org): amino acids 1-583 (Prp40wt), 1-75                  GST-FF domain fusion proteins GST cou-
(Prp40WW1-2); 129–560 (Prp40FF1-4); 129–428                     pled glutathione-Sepharose beads (Amersham Pharma-
(Prp40FF1-3);     129–264    (Prp40FF1-2);    196–428           cia Biotech) incubated 4 μl vitro-translated
(Prp40FF2-3);     351–560    (Prp40FF3-4);    129–201           proteins pulldown buffer (40 mM Hepes pH 8.0; 2.5
(Prp40FF1); 196–264 (Prp40FF2); 351–428 (Prp40FF3);             mM MgCl2; 0,1 mM EDTA; 1 mM DTT; 1 mM PMSF; 0,2 
487–560 (Prp40FF4); 1–620 (Snu71 wt); 530–620                   Triton-X-100; 100 mM NaCl) 2 h 4°C rota-
(Snu71I); 329–536 (Snu71 II).                                   tion. Beads bound proteins washed times
                                                                 10 min rotation 4°C) pulldown buffer
Luc7 constructs created using existing restriction sites   proteins harvested SDS-sample buffer, separated open reading frame (Luc7I: StuI, DNA                 SDS-PAGE, analyzed autoradiography.
position429; Luc7II, EcoRI DNA position 274).
                                                                2.5. Peptide SPOT synthesis
Constructs expressing Gal4DBD- Gal4AD-ORF               Cellulose membrane-bound peptides prepared
fusions verified DNA sequencing.                        according standard SPOT synthesis protocols [41,42]
                                                                using automated Spot synthesizer (MultiPep, Intavis
2.2. Hybrid Screens, Retests Mapping                    AG Bioanalytical Instruments, Köln, Germany); Fmoc
Experiments                                                     derivatives amino-acids peptide synthesis array containing ~6,000 Saccharomyces cer-       obtained Novabiochem. generated peptide
evisiae ORFs expressed Gal4AD fusions used            arrays synthesized amino-PEG membranes
screen interacting proteins. Haploid transformants          (Intavis AG Bioanalytical Instruments, Köln, Germany) expressing length Gal4DBD-ORF fusion pro-         β-alanine membranes. β-alanine membranes pro-
tein Gal4DBD-FF domain construct fusion protein            duced using hardened low ash whatman 50 paper incu- mated array [36]. resulting diploids       bated night Fmoc-β-alanine. Fmoc-
pinned Biomek 2000 Laboratory Automation                 deprotection membranes spotted Fmoc-β-
Workstation (Beckman-Coulter, Fullerton, CA)               alanine-Opfp (Bachem AG, Switzerland) spacer.
selective media described [36]. Positive prey
clones round screen arrayed       2.6. SPOT Membrane Probing
tested single tests reproducibility. Deletion        activation membranes methanol structs mapping yeast hybrid tests             membrane-bound peptide arrays blocked 3 h obtained PCR digestion compatible          blocking buffer (2  milk powder 5  sucrose Tris-
restriction enzymes  section 2.1). constructs         buffered saline (TBS), pH 8.0) incubated  tested preys existing Prp40 FF bait       night 4°C 10 μg/ml purified GST fusion protein constructs using standard Y2H protocols used       GST control protein blocking buffer. washing genome-wide screens.                                    times TBS membranes probed                                                                 anti-GST antibody (G1160; Sigma-Aldrich, München,
2.3. Protein Expression                                         Germany) blocking buffer 0.2  Tween 3 h.
GST GST-Prp40 constructs expressed                  membrane washed times TBS Escherichia coli BL21 purified using glutathione            incubated 1.5 h horseradish-peroxidase-coupled
Sepharose 4B beads (Amersham Pharmacia, Uppsala,                anti-mouse mAb (Sigma-Aldrich; München, Germany) Sweden) described [40].                                   blocking buffer 0.2  Tween followed washing
                                                                times TBS. Analysis quantification pep-
2.4. GST pull assays                                       tide-bound GST fusion proteins carried using
Modified primers Luc7 Snu71, containing T7            ECL (Amersham Biosciences, Freiburg, Germany).
promotor eukaryotic translation initiation site      QRALAKDLIVPRRP known bind GST used used generate PCR products use TNT™-cou-        positive control.



                                                                                                                   Page 9 11
                                                                                             (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                                     http://www.biomedcentral.com/1471-2091/9/29



2.7. vivo FF-domain Deletion                                                References order delete FF domain vivo PCR products                     1.    Abovich N, Rosbash M: Cross-intron bridging interactions                                                                                      yeast commitment complex conserved mammals.
created containing protein kanMX6 cassette                              Cell 1997, 89(3):403-412.
pYM8-plasmid [43] recombined                               2.    Käufer NF, Potashkin J: Analysis splicing machinery fis-
Prp40 locus replaced endogenous FF                                    sion yeast: comparison budding yeast mammals.
                                                                                     Nucleic Acids Res 2000, 28(16):3003-3010.
domains shown Fig. 4A. PCR-constructs trans-                        3.    Gornemann J, Kotovic KM, Hujer K, Neugebauer KM: Cotranscrip-
formed PJ69-4α strain plated geniticin                               tional spliceosome assembly occurs stepwise fashion plates [200 mg/l] selection. Genomic DNA pre-                                requires cap binding complex. Mol Cell 2005, 19(1):53-63.
                                                                               4.    Seraphin B, Rosbash M: Mutational analysis interactions
pared geniticin positive colonies correct                               U1 small nuclear RNA pre-mRNA yeast.
deletion verified PCR. PCR-products recombina-                                Gene 1989, 82(1):145-151.
                                                                               5.    Seraphin B, Rosbash M: Identification functional U1 snRNA-
tion prepared using following primers:                                      pre-mRNA complexes committed spliceosome assembly
Prp40ProA: Forward, GCG TCA AAA AAG AGG CAT TTA                                      splicing. Cell 1989, 59(2):349-358.
ACT CCG GCT GTG GAA TTG GAC TAT CGT ACG CTG                                    6.    Seraphin B, Rosbash M: yeast branchpoint sequence                                                                                      required formation stable U1 snRNA-pre-mRNA
CAG GTC GAC, Reverse, ATA ATT TAT ATA ATG ATT AAC                                    complex recognized absence U2 snRNA.
AAG ATA GAG GTC GAC ACG TCA GAA ATC GAT GAA                                          Embo J 1991, 10(5):1209-1216.
TTC GAG CTC G; ΔFF4ProA: Forward, AGA AAC GAA                                  7.    Michaud S, Reed R: functional association 5'                                                                                      3' splice site established earliest prespliceosome
AAG ATA CAA CAG AAA CTC CAA AAT GAG CGT AGG                                          complex (E) mammals. Genes Dev 1993, 7(6):1008-1020.
ATA CGT ACG CTG CAG GTC GAC Reverse, ATA ATT TAT                               8.    Michaud S, Reed R: ATP-independent complex commits
                                                                                     pre-mRNA mammalian spliceosome assembly path-
ATA ATG ATT AAC AAG ATA GAG GTC GAC ACG TCA                                          way. Genes Dev 1991, 5(12B):2534-2546.
GAA ATC GAT GAA TTC GAG CTC G; ΔFF3-4ProA:                                 9.    Stark H, Dube P, Lührmann R, Kästner B: Arrangement RNA
ward, CTT CAA AAC AAA CTA AAT GAG CTC CGA CTG                                        proteins spliceosomal U1 small nuclear ribonucle-
                                                                                     oprotein particle. Nature 2001, 409(6819):539-542.
CGC AAT TAT ACC AGA CGT ACG CTG CAG GTC GAC;                                   10.   Stevens SW, Ryan  Ge HY, Moore  Young MK, Lee TD, Abel-
Reverse, ATA ATT TAT ATA ATG ATT AAC AAG ATA GAG                                     son J: Composition functional characterization                                                                                      yeast spliceosomal penta-snRNP. Mol Cell 2002, 9(1):31-44.
GTC GAC ACG TCA GAA ATC GAT GAA TTC GAG CTC G;                                 11.   Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y: compre-
ΔFF2-4ProA: Forward, CTT TCC AAT AGA TCA GCC GAT                                     hensive hybrid analysis explore yeast protein
CAA CTT CTT AAG GAA CAC AAT GAA CGT ACG CTG                                          interactome. Proc Natl Acad Sci USA 2001, 98(8):4569-4574.
                                                                               12.   Neubauer G, Gottschalk  Fabrizio P, Seraphin B, Lührmann R, Mann
CAG GTC GAC, Reverse, ATA ATT TAT ATA ATG ATT AAC                                    M: Identification proteins yeast U1 small nuclear
AAG ATA GAG GTC GAC ACG TCA GAA ATC GAT GAA                                          ribonucleoprotein complex mass spectrometry. Proc Natl
TTC GAG CTC G. Control primers verification                               Acad Sci USA 1997, 94(2):385-390.
                                                                               13.   Gottschalk  Tang J, Puig O, Salgado J, Neubauer G, Colot HV, Mann
successful recombination: Forward, GGA CGA ACT ATA                                   M, Seraphin B, Rosbash M, Lührmann R, et al.: comprehensive
AAC GAG (Prp40 specific bp 322–339); Reverse, GTC GAC                                biochemical genetic analysis yeast U1 snRNP
                                                                                     reveals novel proteins. Rna 1998, 4(4):374-393.
CTG CAG CGT ACG (pYM8 specific S3R primer [43].                                14.   Bedford MT, Leder P: FF domain: novel motif                                                                                      accompanies WW domains.                   Trends Biochem Sci 1999, determine growth rate FF deletion strains cell                         24(7):264-265.
                                                                               15.   Letunic  Copley RR, Pils B, Pinkert S, Schultz J, Bork P: SMART 5:
densities (OD600) normalized measured                                  domains context genomes networks. Nucleic
hourly 540 min.                                                                 Acids Res 2006:D257-260.
                                                                               16.   Allen M, Friedler  Schon O, Bycroft M: structure FF
                                                                                     domain human HYPA/FBP11.                       J Mol Biol 2002,
Authors' contributions                                                               323(3):411-416.
PU conceived study. PU CE performed yeast                         17.   Gasch  Wiesner S, Martin-Malpartida P, Ramirez-Espain X, Ruiz L,
                                                                                     Macias MJ: structure Prp40 FF1 domain interac- hybrid screens. CE mapped interaction domains, car-                              tion crn-TPR1 motif Clf1 gives new insight ried pull-downs, SPOT-synthesis mapping                              binding mode FF domains.                    J Biol Chem 2006,
experiments. CE vivo FF domain dele-                                281(1):356-364.
                                                                               18.   Bonet R, Ramirez-Espain X, Macias MJ: Solution structure tions characterized phenotype. CE PU wrote                             yeast URN1 splicing factor FF domain: Comparative analysis paper. authors read approved final manu-                             charge distributions FF domain structures-FFs                                                                                      SURPs, domains similar fold. Proteins 2008,
script.                                                                              73(4):1001-9.
                                                                               19.   Jiang W, Sordella R, Chen GC, Hakre S, Roy AL, Settleman J: FF
Acknowledgements                                                                     domain-dependent protein interaction mediates signaling
                                                                                     pathway growth factor-induced gene expression. Mol Cell project initiated laboratory Stan Fields, University           2005, 17(1):23-35.
Washington, Seattle. like thank Simone Reber help         20.   Carty SM, Goldstrohm AC, Sune C, Garcia-Blanco MA, Greenleaf AL:
cloning FF domains, Christiane Landgraf peptide spotting, Nils Johns-         Protein-interaction modules organize nuclear function:
son providing vectors Tanja Kuhn technical assistance.              FF domains CA150 bind phosphoCTD RNA
                                                                                     polymerase II. Proc Natl Acad Sci USA 2000, 97(16):9015-9020.
work funded J Craig Venter Institute DFG grant Ue 50/2       21.   Goldstrohm AC, Albrecht TR, Sune C, Bedford MT, Garcia-Blanco
PU.                                                                                  MA: transcription elongation factor CA150 interacts
                                                                                     RNA polymerase II pre-mRNA splicing factor
                                                                                     SF1. Mol Cell Biol 2001, 21(22):7617-7628.




                                                                                                                                        Page 10 11
                                                                                                                   (page number citation purposes)
 BMC Biochemistry 2008, 9:29                                                                    http://www.biomedcentral.com/1471-2091/9/29



22.   Morris DP, Greenleaf AL: splicing factor, Prp40, binds       phosphorylated carboxyl-terminal domain RNA polymer-
      ase II. J Biol Chem 2000, 275(51):39935-39943.
23.   Smith MJ, Kulkarni S, Pawson T: FF domains CA150 bind tran-
      scription splicing factors multiple weak interac-
      tions. Mol Cell Biol 2004, 24(21):9274-9285.
24.   Chung S, McLean MR, Rymond BC: Yeast ortholog Dro-
      sophila crooked neck protein promotes spliceosome assem-
      bly stable U4/U6.U5 snRNP addition. Rna 1999,
      5(8):1042-1054.
25.   Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lock-
      shon D, Narayan V, Srinivasan M, Pochart P, et al.: comprehen-
      sive     analysis         protein-protein       interactions         Saccharomyces cerevisiae. Nature 2000, 403(6770):623-627.
26.   Fortes P, Bilbao-Cortes D, Fornerod M, Rigaut G, Raymond W,
      Seraphin B, Mattaj IW: Luc7p, novel yeast U1 snRNP protein
      role 5' splice site recognition. Genes Dev 1999,
      13(18):2425-2438.
27.   Hochleitner EO, Kästner B, Fröhlich T, Schmidt  Lührmann R,
      Arnold G, Lottspeich F: Protein stoichiometry multiprotein
      complex, human spliceosomal U1 small nuclear ribonu-
      cleoprotein: absolute quantification using isotope-coded
      tags mass spectrometry.                    J Biol Chem 2005,
      280(4):2536-2542.
28.   Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer 
      Schultz J, Rick JM, Michon  Cruciat CM, et al.: Functional organ-
      ization yeast proteome systematic analysis pro-
      tein complexes. Nature 2002, 415(6868):141-147.
29.   Puig O, Gottschalk  Fabrizio P, Seraphin B: Interaction U1
      snRNP nonconserved intronic sequences affects 5'
      splice site selection. Genes Dev 1999, 13(5):569-580.
30.   Zhang D, Rosbash M: Identification proteins cross-
      link pre-mRNA yeast commitment complex. Genes
      Dev 1999, 13(5):581-592.
31.   Murphy MW, Olson BL, Siliciano PG: yeast splicing factor
      Prp40p contains functional leucine-rich nuclear export sig-
      nals essential splicing. Genetics 2004, 166(1):53-65.
32.   Newo  Lützelberger M, Bottner CA, Wehland J, Wissing J, Jänsch
      L, Käufer NF: Proteomic analysis U1 snRNP       Schizosaccharomyces pombe reveals essential organ-
      ism-specific proteins. Nucleic Acids Res 2007, 35(5):1391-1401.
33.   Ares M Jr, Proudfoot NJ: spanish connection: transcription
      mRNA processing closer.                      Cell 2005,
      120(2):163-166.
34.   Lin KT, Lu RM, Tarn WY: WW domain-containing proteins
      interact early spliceosome participate pre-
      mRNA splicing vivo. Mol Cell Biol 2004, 24(20):9176-9185.
35.   Proudfoot NJ, Furger  Dye MJ: Integrating mRNA processing
      transcription. Cell 2002, 108(4):501-512.
36.   Cagney G, Uetz P, Fields S: High-throughput screening pro-
      tein-protein interactions using hybrid assay. Methods
      Enzymol 2000, 328:3-14.
37.   Ma H, Kunes S, Schatz PJ, Botstein D: Plasmid construction       homologous recombination yeast. Gene 1987, 58(2–
      3):201-216.
38.   Ito H, Fukuda Y, Murata K, Kimura  Transformation intact
      yeast cells treated alkali cations. J Bacteriol 1983,
      153(1):163-168.
39.   James P, Halladay J, Craig EA: Genomic libraries host strain
      designed highly efficient hybrid selection yeast.
      Genetics 1996, 144(4):1425-1436.                                                Publish Bio Med Central 40.   Ron D, Dressler H: pGSTag – versatile bacterial expression
      plasmid enzymatic labeling recombinant proteins. Bio-                   scientist read work free charge
      techniques 1992, 13(6):866-869.                                            "BioMed Central significant development 41.   Frank R: Spot-Synthesis – Easy Technique Position-              disseminating results biomedical researc h lifetime."
      ally Addressable, Parallel Chemical Synthesis Mem-
      brane Support. Tetrahedron 1992, 48(42):9217-9232.                              Sir Paul Nurse, Cancer Research UK
42.   Frank R: SPOT-synthesis technique. Synthetic peptide                      research papers 
      arrays membrane supports – principles applications.
      J Immunol Methods 2002, 267(1):13-26.                                           available free charge entire biomedical community
43.   Knop M, Siegers K, Pereira G, Zachariae W, Winsor B, Nasmyth K,                 peer reviewed published immediately acceptance
      Schiebel E: Epitope tagging yeast genes using PCR-based
      strategy: tags improved practical routines. Yeast                      cited PubMed archived PubMed Central
      1999, 15(10B):963-972.                                                          — copyright

                                                                             Submit manuscript                                 BioMedcentral
                                                                             http://www.biomedcentral.com/info/publishing_adv.asp




                                                                                                                                            Page 11 11
                                                                                                             